August 20, 2025Sonography

Limitations of Estrogen–Progestogen Therapy for Vascular Retained Products of Conception: Insights From Two Treatment‐Resistant Cases

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Case reports reveal ineffective estrogen-progestogen therapy for vascular retained products of conception, highlighting treatment challenges.

Estrogen-progestogen therapy fails to address vascular retained products of conception, leading to further complications.
In one case, two cycles of therapy did not resolve the lesion, revealing an angular pregnancy during imaging.
Patients with anatomically aberrant implantation may require alternative treatments instead of standard therapy.
These findings indicate a need for revised treatment protocols for managing vascular retained products of conception.

Yamaguchi et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Case reports reveal ineffective estrogen-progestogen therapy for vascular retained products of conception, highlighting treatment challenges.